John A Roberts - Net Worth and Insider Trading
John A Roberts Net Worth
The estimated net worth of John A Roberts is at least $47,280 dollars as of 2024-12-27. John A Roberts is the CEO of Cancer Genetics Inc and owns about 9,921 shares of Cancer Genetics Inc (CGIX) stock worth over $45,736. John A Roberts is also the CEO of Vyant Bio Inc and owns about 7,961 shares of Vyant Bio Inc (VYNT) stock worth over $1,544. Details can be seen in John A Roberts's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John A Roberts has not made any transactions after 2021-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John A Roberts
John A Roberts Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John A Roberts owns 2 companies in total, including Cancer Genetics Inc (CGIX) , and Vyant Bio Inc (VYNT) .
Click here to see the complete history of John A Roberts’s form 4 insider trades.
Insider Ownership Summary of John A Roberts
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CGIX | Cancer Genetics Inc | 2019-01-31 | Chief Executive Officer |
VYNT | Vyant Bio Inc | 2021-11-24 | Chief Executive Officer |
John A Roberts Latest Holdings Summary
John A Roberts currently owns a total of 2 stocks. Among these stocks, John A Roberts owns 9,921 shares of Cancer Genetics Inc (CGIX) as of January 31, 2019, with a value of $45,736 and a weighting of 96.73%. John A Roberts also owns 7,961 shares of Vyant Bio Inc (VYNT) as of November 24, 2021, with a value of $1,544 and a weighting of 3.27%.
Latest Holdings of John A Roberts
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CGIX | Cancer Genetics Inc | 2019-01-31 | 9,921 | 4.61 | 45,736 |
VYNT | Vyant Bio Inc | 2021-11-24 | 7,961 | 0.19 | 1,544 |
Holding Weightings of John A Roberts
John A Roberts Form 4 Trading Tracker
According to the SEC Form 4 filings, John A Roberts has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 6,181 shares on January 31, 2019, which cost John A Roberts around $42,650.
According to the SEC Form 4 filings, John A Roberts has made a total of 3 transactions in Vyant Bio Inc (VYNT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Vyant Bio Inc is the acquisition of 1,000 shares on November 24, 2021, which cost John A Roberts around $10,100.
Insider Trading History of John A Roberts
- 1
John A Roberts Trading Performance
GuruFocus tracks the stock performance after each of John A Roberts's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John A Roberts is -16.08%. GuruFocus also compares John A Roberts's trading performance to market benchmark return within the same time period. The performance of stocks bought by John A Roberts within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John A Roberts's insider trading performs compared to the benchmark.
Performance of John A Roberts
John A Roberts Ownership Network
John A Roberts Owned Company Details
What does Cancer Genetics Inc do?
Who are the key executives at Cancer Genetics Inc?
John A Roberts is the Chief Executive Officer of Cancer Genetics Inc. Other key executives at Cancer Genetics Inc include President & Discovery Services Ralf Brandt , Chief Financial Officer Michael Glenn Miles , and EVP Precision Medicine William Lansing Finger .
Cancer Genetics Inc (CGIX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cancer Genetics Inc (CGIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cancer Genetics Inc (CGIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cancer Genetics Inc (CGIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cancer Genetics Inc Insider Transactions
John A Roberts Mailing Address
Above is the net worth, insider trading, and ownership report for John A Roberts. You might contact John A Roberts via mailing address: C/o Cancer Genetics, Inc., 201 Route 17 North, 2nd Floor, Rutherford Nj 07070.